Goldman Sachs’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $58.9M | Buy |
2,095,800
+855,800
| +69% | +$22.8M | 0.01% | 1445 |
|
|
2025
Q4 | $30.9M | Buy |
1,240,000
+300,000
| +32% | +$7.57M | ﹤0.01% | 1948 |
|
|
2025
Q3 | $24M | Sell |
940,000
-244,300
| -21% | -$6.03M | ﹤0.01% | 2093 |
|
|
2025
Q2 | $28.7M | Buy |
1,184,300
+530,000
| +81% | +$12.4M | ﹤0.01% | 1797 |
|
|
2025
Q1 | $16.6M | Buy |
654,300
+324,000
| +98% | +$8.48M | ﹤0.01% | 2204 |
|
|
2024
Q4 | $8.76M | Sell |
330,300
-184,500
| -36% | -$5M | ﹤0.01% | 2924 |
|
|
2024
Q3 | $14.9M | Sell |
514,800
-14,000
| -3% | -$408K | ﹤0.01% | 2324 |
|
|
2024
Q2 | $14.8M | Buy |
528,800
+12,300
| +2% | +$339K | ﹤0.01% | 2136 |
|
|
2024
Q1 | $14.3M | Sell |
516,500
-196,700
| -28% | -$5.46M | ﹤0.01% | 2137 |
|
|
2023
Q4 | $20.5M | Sell |
713,200
-1,065,000
| -60% | -$32.2M | ﹤0.01% | 1858 |
|
|
2023
Q3 | $59M | Buy |
1,778,200
+1,095,500
| +160% | +$38.7M | 0.01% | 1009 |
|
|
2023
Q2 | $25M | Sell |
682,700
-18,000
| -3% | -$701K | 0.01% | 1659 |
|
|
2023
Q1 | $28.6M | Sell |
700,700
-668,000
| -49% | -$28.9M | 0.01% | 1493 |
|
|
2022
Q4 | $70.1M | Sell |
1,368,700
-112,600
| -8% | -$5.4M | 0.02% | 917 |
|
|
2022
Q3 | $64.8M | Sell |
1,481,300
-70,800
| -5% | -$3.44M | 0.02% | 935 |
|
|
2022
Q2 | $81.4M | Sell |
1,552,100
-143,200
| -8% | -$7.3M | 0.02% | 816 |
|
|
2022
Q1 | $87.8M | Sell |
1,695,300
-64,700
| -4% | -$3.36M | 0.02% | 846 |
|
|
2021
Q4 | $104M | Buy |
1,760,000
+403,300
| +30% | +$20M | 0.02% | 789 |
|
|
2021
Q3 | $58.4M | Buy |
1,356,700
+286,200
| +27% | +$12.7M | 0.01% | 1173 |
|
|
2021
Q2 | $41.9M | Buy |
1,070,500
+515,000
| +93% | +$20M | 0.01% | 1413 |
|
|
2021
Q1 | $20.1M | Buy |
555,500
+394,500
| +245% | +$14M | 0.01% | 1926 |
|
|
2020
Q4 | $5.93M | Buy |
161,000
+81,950
| +104% | +$3.01M | ﹤0.01% | 2892 |
|
|
2020
Q3 | $2.75M | Buy |
+79,050
| New | +$2.77M | ﹤0.01% | 3343 |
|
|
2020
Q1 | – | Sell |
-85,269
| Closed | -$3.17M | – | 5472 |
|
|
2019
Q4 | $3.17M | Sell |
85,269
-105,400
| -55% | -$3.75M | ﹤0.01% | 3310 |
|
|
2019
Q3 | $6.5M | Sell |
190,669
-716,087
| -79% | -$26M | ﹤0.01% | 2662 |
|
|
2019
Q2 | $37.3M | Sell |
906,756
-1,572,990
| -63% | -$62.5M | 0.01% | 1364 |
|
|
2019
Q1 | $99.9M | Buy |
2,479,746
+1,405,509
| +131% | +$56.3M | 0.03% | 666 |
|
|
2018
Q4 | $44.5M | Buy |
1,074,237
+290,904
| +37% | +$12.1M | 0.01% | 1177 |
|
|
2018
Q3 | $32.8M | Sell |
783,333
-223,869
| -22% | -$8.62M | 0.01% | 1539 |
|
|
2018
Q2 | $34.7M | Sell |
1,007,202
-503,285
| -33% | -$17.2M | 0.01% | 1494 |
|
|
2018
Q1 | $50.9M | Sell |
1,510,487
-661,280
| -30% | -$22.7M | 0.01% | 1187 |
|
|
2017
Q4 | $74.6M | Buy |
2,171,767
+131,012
| +6% | +$4.47M | 0.02% | 987 |
|
|
2017
Q3 | $69.1M | Buy |
2,040,755
+61,343
| +3% | +$1.97M | 0.02% | 1058 |
|
|
2017
Q2 | $63.1M | Buy |
1,979,412
+421,073
| +27% | +$13.3M | 0.02% | 1088 |
|
|
2017
Q1 | $50.6M | Sell |
1,558,339
-12,882,620
| -89% | -$406M | 0.01% | 1213 |
|
|
2016
Q4 | $445M | Sell |
14,440,959
-672,558
| -4% | -$20.5M | 0.13% | 143 |
|
|
2016
Q3 | $486M | Buy |
15,113,517
+428,557
| +3% | +$14.3M | 0.15% | 104 |
|
|
2016
Q2 | $491M | Sell |
14,684,960
-7,357,026
| -33% | -$235M | 0.16% | 96 |
|
|
2016
Q1 | $620M | Sell |
22,041,986
-1,727,190
| -7% | -$49.3M | 0.2% | 74 |
|
|
2015
Q4 | $728M | Buy |
23,769,176
+15,047,326
| +173% | +$473M | 0.23% | 67 |
|
|
2015
Q3 | $260M | Buy |
8,721,850
+5,338,088
| +158% | +$171M | 0.09% | 223 |
|
|
2015
Q2 | $108M | Sell |
3,383,762
-11,339,142
| -77% | -$370M | 0.03% | 615 |
|
|
2015
Q1 | $486M | Buy |
14,722,904
+12,824,650
| +676% | +$408M | 0.16% | 122 |
|
|
2014
Q4 | $56.1M | Sell |
1,898,254
-294,804
| -13% | -$8.45M | 0.02% | 1018 |
|
|
2014
Q3 | $61.5M | Sell |
2,193,058
-907,494
| -29% | -$25.5M | 0.02% | 924 |
|
|
2014
Q2 | $87.3M | Buy |
3,100,552
+384,394
| +14% | +$11M | 0.03% | 740 |
|
|
2014
Q1 | $82.8M | Sell |
2,716,158
-431,402
| -14% | -$12.9M | 0.03% | 706 |
|
|
2013
Q4 | $91.5M | Buy |
3,147,560
+172,961
| +6% | +$5.03M | 0.03% | 671 |
|
|
2013
Q3 | $81.1M | Sell |
2,974,599
-2,075,220
| -41% | -$56.5M | 0.03% | 684 |
|
|
2013
Q2 | $134M | Buy |
+5,049,819
| New | +$140M | 0.05% | 420 |
|
Other funds holding PFE
VCM
VPM
Goldman Sachs's PFE Position: Q1 2026 in Review
Goldman Sachs increased its Pfizer (PFE) stake by 18% in Q1 2026, buying an estimated $188M and bringing the position to 47,105,556 shares worth $1.32B. The position accounts for 0.15% of the portfolio, ranked #113.
Goldman Sachs first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $3.14B in Q1 2016. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Goldman Sachs held 47,105,556 shares of Pfizer worth $1.32B as of Q1 2026.
- Goldman Sachs bought 7,049,994 Pfizer shares in Q1 2026, an estimated $188M.
- Pfizer made up 0.15% of Goldman Sachs's portfolio in Q1 2026, its #113 holding.
- Goldman Sachs first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Goldman Sachs's Pfizer position peaked at $3.14B in Q1 2016.
- 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.